CHEST Physician
-
Coadministration safety of influenza, pertussis vaccines during pregnancy confirmed by large data set
Experts said the results, which showed no difference in outcomes such as preterm birth and low birth weight, may help improve prenatal vaccine uptake by reducing additional appointments for patients.
-
HI-PEITHO confirms benefit of USCDT in intermediate-risk pulmonary embolism
Investigator Frederikus A. Klok, MD, PhD, said he expects additional evidence to be published in the coming year, which will shape future guidelines and clinical management of patients with intermediate-high risk pulmonary embolism.
-
Study evaluates sleep efficiency change in patients with pediatric OSA following adenotonsillectomy
Pediatric pulmonologist Anne C. Coates, MD, said it may take longer to see a benefit from surgery in some populations, especially when nonrespiratory factors may be affecting sleep efficiency.
-
Advancing postarrest care in the ICU
New evidence suggests prophylactic antibiotics and biomarkers like neuron-specific enolase may help improve prevention and prognostication of cardiac arrest, offering a more proactive approach to postarrest care.
-
Steroids in pneumonia: The end of an era?
Emerging data suggest a potential expanding role for corticosteroids in severe cases of community-acquired pneumonia, though it remains uncertain whether this approach should extend to nonsevere or outpatient settings.
-
Mucus plugging in severe asthma: Clinical significance and emerging therapeutic targets
As image-based markers become increasingly integrated into severe asthma phenotyping, the mucus plug score may evolve into a clinically actionable tool.
-
Orexin receptor agonists: The evolution of precision medicine in narcolepsy type 1
This kind of therapy represents a promising and exciting step toward a precision medicine approach that directly targets the underlying deficiency of orexin signaling in narcolepsy type 1.
-
Opportunity, leadership, and the mindset for change
CHEST President Neil Freedman, MD, FCCP, reflects on the essence of leadership, mentorship, and the future of chest medicine.
-
The evolution of interventional pulmonology
Interventional pulmonology has rapidly evolved into a technology-driven specialty, with advances like robotic bronchoscopy and real-time imaging enabling safer, more precise access to peripheral lung lesions. These innovations allow clinicians to combine diagnostic and therapeutic procedures in a single setting.
-
DPP-1 inhibitors enter clinical practice
Sunjay R. Devarajan, MD, FCCP, and Anas Hadeh, MD, FCCP, said DPP-1 inhibitors are expected to become a new standard of care, with ongoing studies further defining their role in noncystic fibrosis bronchiectasis management.
